Worm enzyme trial hopes to tame Crohn's Flare-Ups
NCT ID NCT02281916
First seen Dec 26, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This early study tested whether a protein from a parasite (P28GST) is safe for people with moderate Crohn's disease. Ten adults with ileal or ileo-colic Crohn's received the treatment before or after bowel surgery. The goal was to see if it could control inflammation without causing serious side effects. Results focus on safety and changes in immune markers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S ILEOCOLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU, Hôpital Claude Huriez
Lille, 59037, France
-
Centre Hospitalier Dunkerque
Dunkirk, France
-
Centre Hospitalier de Boulogne
Boulogne-sur-Mer, France
-
Centre Hospitalier,
Valenciennes, France
-
Centre hospitalier
Amiens, France
Conditions
Explore the condition pages connected to this study.